Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Gains from Investment Securities (2021 - 2025)

Zymeworks' Gains from Investment Securities history spans 3 years, with the latest figure at $978000.0 for Q4 2023.

  • For Q4 2023, Gains from Investment Securities rose 270.45% year-over-year to $978000.0; the TTM value through Dec 2023 reached $1.9 million, up 13471.43%, while the annual FY2025 figure was $2.4 million, 279.35% up from the prior year.
  • Gains from Investment Securities for Q4 2023 was $978000.0 at Zymeworks, up from $528000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $978000.0 in Q4 2023 and bottomed at -$322000.0 in Q3 2022.
  • The 3-year median for Gains from Investment Securities is $223000.0 (2021), against an average of $262000.0.
  • The largest annual shift saw Gains from Investment Securities surged 45.05% in 2022 before it surged 427.78% in 2023.
  • A 3-year view of Gains from Investment Securities shows it stood at $182000.0 in 2021, then surged by 45.05% to $264000.0 in 2022, then surged by 270.45% to $978000.0 in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Gains from Investment Securities are $978000.0 (Q4 2023), $528000.0 (Q3 2023), and $380000.0 (Q2 2023).